Cortrophin Gel: An “Old” Treatment Making a Comeback for Difficult Gout Flares

    Cortrophin Gel: An “Old” Treatment Making a Comeback for Difficult Gout Flares

    Gout is one of the most painful inflammatory conditions affecting the foot and ankle. While many patients respond well to standard therapies, a subset continue to suffer from severe flare-ups despite conventional treatment. At the Advanced Foot and Ankle Center of San Diego, emerging and rediscovered therapies are being utilized when first-line treatments fail—one of which is Cortrophin Gel.

    Understanding Gout Flares

     

     

     

     

    Image

     

    Gout is caused by deposition of monosodium urate crystals within joints, most commonly the first metatarsophalangeal (big toe) joint. This triggers an intense inflammatory cascade characterized by:

    • Severe pain (often sudden onset, frequently at night)
    • Redness and warmth
    • Marked swelling
    • Difficulty bearing weight

    Standard treatment options include:

    • NSAIDs
    • Colchicine
    • Prednisone

    However, not all patients tolerate or respond adequately to these therapies.

    When Prednisone Fails: A Therapeutic Challenge

     

    Image

     

     

     

     

    Although Prednisone is a powerful anti-inflammatory corticosteroid, there are situations where it may be:

    • Ineffective in controlling the flare
    • Contraindicated (e.g., poorly controlled diabetes, infection risk)
    • Poorly tolerated due to systemic side effects

    For these patients, alternative mechanisms of action become critically important.

    Cortrophin Gel: Mechanism and Clinical Relevance

    Image

    Image

     

    Image

     

    Cortrophin Gel is a purified adrenocorticotropic hormone (ACTH) analog that stimulates the adrenal cortex to produce endogenous corticosteroids and other anti-inflammatory mediators.

    Why this matters clinically:

    Unlike prednisone, which delivers exogenous steroids, Cortrophin Gel:

    • Activates the body’s natural steroid production pathways
    • Stimulates additional adrenal-derived hormones beyond cortisol
    • May produce a broader immunomodulatory effect
    • Can be effective in steroid-resistant or refractory gout flares

    This difference in mechanism is key—Cortrophin is not simply “another steroid,” but rather a neuroendocrine modulator that leverages the hypothalamic-pituitary-adrenal (HPA) axis.

    Clinical Advantages in Refractory Gout

    ImageFor patients who have failed prednisone, Cortrophin Gel offers several potential advantages:

    • Alternative pathway activation when direct steroids are insufficient
    • Reduced reliance on high-dose systemic corticosteroids
    • Utility in patients with multiple medication intolerances
    • Potential benefit in complex inflammatory profiles

    It is particularly useful in:

    • Recurrent gout flares
    • Patients with comorbidities limiting NSAIDs or steroids
    • Cases where rapid symptom control is still required

    Practical Considerations Image

    Cortrophin Gel is administered via subcutaneous or intramuscular injection and is typically reserved for select cases due to:

    • Cost considerations
    • Insurance authorization requirements
    • Need for physician-directed use

    At the Advanced Foot and Ankle Center of San Diego, this therapy is considered when standard protocols fail, ensuring patients still have access to effective relief options.

    The Takeaway

    While gout treatment has remained largely unchanged for decades, revisiting older therapies like Cortrophin Gel provides a valuable tool in modern practice. For patients who do not respond to prednisone, this “old but new” treatment may offer meaningful relief through a completely different biologic mechanism.